Management of Asymptomatic AR & MR

Overview

  • Discusses the assessment and management of mitral and aortic regurgitation.

  • Emphasizes case-based learning and feedback.

Mitral Valve Assessment

  • Anatomy:

    • Left atrium and mitral valve characteristics evaluated.

    • Notable prolapse of posterior leaflet over anterior leaflet leading to mitral regurgitation (MR).

  • Echocardiographic Findings:

    • Preserved left ventricular (LV) function

    • Enlarged left atrium (LA)

    • Presence of mitral regurgitation; significant anteriorly directed jet observed.

Stages of Valvular Heart Disease

  • Stage A: At risk for valvular heart disease.

  • Stage B: Mild/moderate MR.

  • Stage C: Severe valvular heart disease (can be asymptomatic or symptomatic).

    • Symptoms impact LV and RV compensation stages.

Early Intervention

  • Emphasizes the importance of early surgical intervention in patients with MR for better outcomes.

  • Historical study indicates improved event-free survival with early surgery compared to conservative management.

  • Highlights critical surgical considerations:

    • Durability of repair >95%

    • Low surgical risk (STS risk score <1%)

Echocardiographic Parameters to Consider

  • Assess severity of regurgitant lesions as either primary or secondary:

    • Primary: Valve issue needing direct repair.

    • Secondary: LV problem needing management before addressing the valve.

  • Effective Regurgitant Orifice (ERO):

    • ERO ≥ 2.4 cm² indicates severe MR.

  • Left Ventricular Measurements:

    • Ejection Fraction (EF) > 60% is optimal.

    • End Systolic Dimension (ESD) > 40 mm raises intervention considerations.

Communication with Surgical Team

  • Importance of collaboration in interpreting echo findings with surgeons.

  • Focus on anatomical details like flail leaflets that are highly repairable.

Management Protocol for Asymptomatic MR

  • Patients with mild to moderate MR should be monitored regularly.

  • Patients with severe MR must be followed closely every 6-12 months regardless of symptoms.

  • Discrepancy between echo findings and physical exams needs to be evaluated with additional imaging (TEE, MRI, CPET for better evaluation of functional capacity).

Aortic Regurgitation Overview

  • Highlights the complexity of assessing and managing aortic regurgitation.

  • Description of a case: asymptomatic patient with significant echocardiographic findings.

  • Key parameters for decision making include:

    • Blood pressure, EKG changes, cardiac silhouette on chest X-ray.

Key Parameters for Decision Making in Aortic Regurgitation

  • Evaluate ERO, regurgitant fraction (RF), and LV dimensions.

  • Symptomatic status and LV response crucial for intervention decision.

    • Thresholds for intervention differ from mitral regurgitation; RF of >55% indicates need for surgical consideration.

  • Asymptomatic patients with increasing LV size and progressive decline in EF are flagged for surgery.

Emerging Concepts and Future Directions in Regurgitation Management

  • Focus on understanding LV morphology changes, biomarkers, and strain as indicators of progressive heart disease.

  • Importance of early intervention to mitigate long-term LV dysfunction before symptoms develop.

  • Recognition of evolving guidelines and surgical techniques for better outcomes in such patients.

  • Consider septal reduction for SAM MR.

Conclusion

  • Early surgical intervention is critical in patients with valvular heart disease to prevent complications.

  • Continuous learning and adaptation of practices are essential in the fast-evolving field of cardiovascular diagnostics and therapeutics.